USP11 Drives Cerebral Ischemia–Reperfusion Injury Via Promoting Ferroptosis by Deubiquitinating and Stabilizing ASK1
6 affiliations
- 1Guangdong Medical University
- 2Wuhan University
- 3Renmin Hospital of Wuhan University
- 4Hubei Minzu University
- 5Jingmen Clinical College of Hubei University of Medicine
- 6Zhengzhou University People's Hospital (Henan Provincial People's Hospital)
Abstract
BACKGROUND: Cerebral ischemia-reperfusion injury (CIRI) represents a pivotal pathological mechanism underlying ischemic cerebrovascular disorders including cerebral stroke. Currently, there are lack of effective preventive or therapeutic methods. Ubiquitin-specific protease 11 (USP11) is a member of the most prevalent ubiquitination-specific protease (USP) family. It has been shown that USP11 plays diverse and significant roles in a variety of diseases, such as hepatocellular carcinoma, prostate cancer, and intervertebral disc degeneration. However, its precise function and molecular mechanisms involvement in CIRI remain unknown. METHODS: USP11 knockout (USP11-KO) and adeno-associated virus 9-mediated USP11 over-expression (USP11-OE) mice were established as a mouse model of CIRI, and USP11 knockdown and overexpression adenovirus were used to establish a cell model, to investigate the effect of USP11 on CIRI in vivo and in vitro. Molecular biological studies were used to clarify the mechanism of USP11 mediated ferroptosis during CIRI. RESULTS: The expression of USP11 is increased during CIRI. Functionally, USP11 deficiency attenuated neurological deficits, cerebral infarction, neuroinflammation, and ferroptosis during CIRI, whereas specific overexpression of USP11 exacerbated these pathological processes. Furthermore, USP11 knockdown inhibited neuronal injury, inflammatory response and ferroptosis, while USP11 overexpression promoted these processes. Mechanistically, USP11 bind to ASK1 and inhibit its K48-linked ubiquitination, thereby enhancing the activity of the ASK1-JNK/p38 signaling pathway. More importantly, the regulation of USP11 on neuronal ferroptosis and CIRI relied on its regulation of the ASK1-JNK/p38 signaling axis. CONCLUSIONS: Our study clarified the new functions and mechanisms of USP11 during CIRI. Targeting USP11-ASK1-JNK/p38-ferroptosis may be a new promising strategy for the prevention and treatment of CIRI.
Related
- Deubiquitinase USP5 suppresses ferroptosis in lung adenocarcinoma by deubiquitinating and stabilizing GPX3.
- The Deubiquitinating Enzyme UCHL1 Promotes Radiotherapy Resistance in Glioma by Stabilizing Keratin 18
- CPSF6 maintains genomic stability by stabilizing RAD52 and promoting CHK1 activation
- PRMT1 facilitates the renal ischemia-reperfusion injury by inducing the ferroptosis via mediating the arginine methylation of ACSL4
- Discovery of metabolite biomarkers for cerebral ischemia-reperfusion injury based on metabolomics: neurotoxic mechanism and functional validation of a flavopiridol -related metabolite
BibTeX
@article{hu2026usp11,
title = {{USP11 Drives Cerebral Ischemia–Reperfusion Injury Via Promoting Ferroptosis by Deubiquitinating and Stabilizing ASK1}},
author = {Sha Hu and KunPeng Wang and Mingcheng He and Yu Zhang and Haitao Wang and Mei Yang and Peng Zhang and Zhaoshuo Li and Zhigang Lu},
journal = {Journal of the American Heart Association},
year = {2026},
month = oct,
doi = {10.1161/jaha.125.046371},
url = {https://www.ahajournals.org/doi/10.1161/JAHA.125.046371},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - USP11 Drives Cerebral Ischemia–Reperfusion Injury Via Promoting Ferroptosis by Deubiquitinating and Stabilizing ASK1
AU - Sha Hu
AU - KunPeng Wang
AU - Mingcheng He
AU - Yu Zhang
AU - Haitao Wang
AU - Mei Yang
AU - Peng Zhang
AU - Zhaoshuo Li
AU - Zhigang Lu
PY - 2026
DA - 2026/10/20
JO - Journal of the American Heart Association
DO - 10.1161/jaha.125.046371
UR - https://www.ahajournals.org/doi/10.1161/JAHA.125.046371
AB - BACKGROUND: Cerebral ischemia-reperfusion injury (CIRI) represents a pivotal pathological mechanism underlying ischemic cerebrovascular disorders including cerebral stroke. Currently, there are lack of effective preventive or therapeutic methods. Ubiquitin-specific protease 11 (USP11) is a member of the most prevalent ubiquitination-specific protease (USP) family. It has been shown that USP11 plays diverse and significant roles in a variety of diseases, such as hepatocellular carcinoma, prostate cancer, and intervertebral disc degeneration. However, its precise function and molecular mechanisms involvement in CIRI remain unknown. METHODS: USP11 knockout (USP11-KO) and adeno-associated virus 9-mediated USP11 over-expression (USP11-OE) mice were established as a mouse model of CIRI, and USP11 knockdown and overexpression adenovirus were used to establish a cell model, to investigate the effect of USP11 on CIRI in vivo and in vitro. Molecular biological studies were used to clarify the mechanism of USP11 mediated ferroptosis during CIRI. RESULTS: The expression of USP11 is increased during CIRI. Functionally, USP11 deficiency attenuated neurological deficits, cerebral infarction, neuroinflammation, and ferroptosis during CIRI, whereas specific overexpression of USP11 exacerbated these pathological processes. Furthermore, USP11 knockdown inhibited neuronal injury, inflammatory response and ferroptosis, while USP11 overexpression promoted these processes. Mechanistically, USP11 bind to ASK1 and inhibit its K48-linked ubiquitination, thereby enhancing the activity of the ASK1-JNK/p38 signaling pathway. More importantly, the regulation of USP11 on neuronal ferroptosis and CIRI relied on its regulation of the ASK1-JNK/p38 signaling axis. CONCLUSIONS: Our study clarified the new functions and mechanisms of USP11 during CIRI. Targeting USP11-ASK1-JNK/p38-ferroptosis may be a new promising strategy for the prevention and treatment of CIRI.
SN - 2047-9980
ER -